Literature DB >> 11817215

Vascular growth factors in cerebral ischemia.

S D Croll1, S J Wiegand.   

Abstract

During the past decade, there has been a surge of interest in growth factors (GFs) that act selectively on vascular endothelium and perivascular cells. Studies employing mutant mice or the administration of recombinant proteins have suggested that these factors not only mediate the proliferation of endothelial cells, but also regulate vascular differentiation, regression, and permeability. During and after cerebral ischemia, brain vasculature becomes leaky and unstable, and the normally impermeable blood-brain barrier breaks down. Several days after the ischemic insult, endothelial cells begin to proliferate, and angiogenesis occurs. Expression studies have shown that key vascular GFs are regulated, during these processes, in a complex and coordinated manner. The distinct pattern of regulation exhibited by each vascular GF suggests a unique role for each factor during the initial vascular destabilization and subsequent angiogenesis that occurs after cerebral ischemia. Data from studies in other biological systems support these suggested roles. Thus, manipulation of vascular GFs may prove to be an effective means of stabilizing or enriching brain vasculature after ischemia, and ameliorating the detrimental effects of blood-brain barrier breakdown and vessel regression after stroke.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11817215     DOI: 10.1385/MN:23:2-3:121

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  113 in total

1.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

Authors:  D W Losordo; P R Vale; J F Symes; C H Dunnington; D D Esakof; M Maysky; A B Ashare; K Lathi; J M Isner
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

Review 2.  Anti-adhesion molecule and nitric oxide protection strategies in ischemic stroke.

Authors:  M Chopp; Z G Zhang
Journal:  Curr Opin Neurol       Date:  1996-02       Impact factor: 5.710

Review 3.  Advances in the vascular pathophysiology of ischemic stroke.

Authors:  G J del Zoppo; J M Hallenbeck
Journal:  Thromb Res       Date:  2000-05-01       Impact factor: 3.944

4.  Evidence for modulation of genes involved in vascular adaptation by prolonged exposure of endothelial cells to shear stress.

Authors:  M Bongrazio; C Baumann; A Zakrzewicz; A R Pries; P Gaehtgens
Journal:  Cardiovasc Res       Date:  2000-08       Impact factor: 10.787

5.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

Review 6.  Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets.

Authors:  G Z Feuerstein; X Wang; F C Barone
Journal:  Ann N Y Acad Sci       Date:  1997-10-15       Impact factor: 5.691

7.  Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.

Authors:  M Iitaka; S Miura; K Yamanaka; S Kawasaki; S Kitahama; Y Kawakami; S Kakinuma; I Oosuga; S Wada; S Katayama
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

8.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

9.  Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis.

Authors:  J D Pearlman; M G Hibberd; M L Chuang; K Harada; J J Lopez; S R Gladstone; M Friedman; F W Sellke; M Simons
Journal:  Nat Med       Date:  1995-10       Impact factor: 53.440

10.  Hypoxic regulation of vascular endothelial growth factor in retinal cells.

Authors:  L P Aiello; J M Northrup; B A Keyt; H Takagi; M A Iwamoto
Journal:  Arch Ophthalmol       Date:  1995-12
View more
  22 in total

1.  Recombinant human angiopoietin-1 ameliorates the expressions of ZO-1, occludin, VE-cadherin, and PKCα signaling after focal cerebral ischemia/reperfusion in rats.

Authors:  Hang Yu; Ping Wang; Ping An; Yixue Xue; Xue Yixue
Journal:  J Mol Neurosci       Date:  2011-06-29       Impact factor: 3.444

Review 2.  Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection.

Authors:  M Slevin; J Krupinski; P Kumar; J Gaffney; S Kumar
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

3.  Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures.

Authors:  Daniel P McCloskey; Susan D Croll; Helen E Scharfman
Journal:  J Neurosci       Date:  2005-09-28       Impact factor: 6.167

Review 4.  Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword.

Authors:  Susan D Croll; Jeffrey H Goodman; Helen E Scharfman
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

5.  Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation.

Authors:  Edward M Conway; Femke Zwerts; Veerle Van Eygen; Astrid DeVriese; Nobuo Nagai; Wei Luo; Désiré Collen
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 6.  The vascular neural network--a new paradigm in stroke pathophysiology.

Authors:  John H Zhang; Jerome Badaut; Jiping Tang; Andre Obenaus; Richard Hartman; William J Pearce
Journal:  Nat Rev Neurol       Date:  2012-10-16       Impact factor: 42.937

7.  Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus.

Authors:  J N Nicoletti; S K Shah; D P McCloskey; J H Goodman; A Elkady; H Atassi; D Hylton; J S Rudge; H E Scharfman; S D Croll
Journal:  Neuroscience       Date:  2007-10-26       Impact factor: 3.590

8.  Cerebral ischemia-reperfusion injury in rats--a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation.

Authors:  Deepu R Pillai; Michael S Dittmar; Dobri Baldaranov; Robin M Heidemann; Erica C Henning; Gerhard Schuierer; Ulrich Bogdahn; Felix Schlachetzki
Journal:  J Cereb Blood Flow Metab       Date:  2009-08-05       Impact factor: 6.200

Review 9.  Triggers and mediators of hemorrhagic transformation in cerebral ischemia.

Authors:  Xiaoying Wang; Eng H Lo
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

10.  Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease.

Authors:  Dwaine F Emerich; David J Mooney; Hannah Storrie; Rangasamy Suresh Babu; Jeffrey H Kordower
Journal:  Neurotox Res       Date:  2009-07-09       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.